This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-125b-5p | MUC1 | -1.94 | 0 | 2.6 | 0 | miRNAWalker2 validate | -0.23 | 0.00041 | NA | |
2 | hsa-miR-145-5p | MUC1 | -2.63 | 0 | 2.6 | 0 | miRNAWalker2 validate; miRTarBase | -0.38 | 0 | 24157791 | MiR 145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1; MiR-145 is found to negatively regulate P70S6K1 and MUC1 protein levels by directly targeting their 3'UTRs; Importantly the overexpression of p70S6K1 and MUC1 can restore the cell colony formation and invasion abilities that are reduced by miR-145 respectively; Our study suggests that miR-145 modulates ovarian cancer growth and invasion by suppressing p70S6K1 and MUC1 functioning as a tumor suppressor |
3 | hsa-miR-326 | MUC1 | -1.54 | 0 | 2.6 | 0 | miRanda | -0.33 | 0 | NA | |
4 | hsa-miR-335-5p | MUC1 | -2.61 | 0 | 2.6 | 0 | miRNAWalker2 validate | -0.33 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | O GLYCAN PROCESSING | 8 | 58 | 3.708e-16 | 1.725e-12 |
2 | GLYCOSYLATION | 10 | 267 | 2.496e-14 | 5.807e-11 |
3 | PROTEIN O LINKED GLYCOSYLATION | 8 | 101 | 3.82e-14 | 5.926e-11 |
4 | GLYCOPROTEIN METABOLIC PROCESS | 10 | 353 | 4.082e-13 | 4.749e-10 |
5 | CARBOHYDRATE METABOLIC PROCESS | 11 | 662 | 6.164e-12 | 5.736e-09 |
6 | CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 10 | 595 | 7.119e-11 | 5.521e-08 |
7 | CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 11 | 1047 | 8.348e-10 | 5.549e-07 |
8 | KERATAN SULFATE BIOSYNTHETIC PROCESS | 4 | 28 | 1.466e-08 | 8.525e-06 |
9 | KERATAN SULFATE METABOLIC PROCESS | 4 | 33 | 2.92e-08 | 1.51e-05 |
10 | GLYCOLIPID BIOSYNTHETIC PROCESS | 4 | 62 | 3.907e-07 | 0.0001818 |
11 | GANGLIOSIDE BIOSYNTHETIC PROCESS | 3 | 18 | 6.911e-07 | 0.0002924 |
12 | SIALYLATION | 3 | 21 | 1.124e-06 | 0.000436 |
13 | GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 3 | 25 | 1.939e-06 | 0.0006942 |
14 | GANGLIOSIDE METABOLIC PROCESS | 3 | 26 | 2.191e-06 | 0.0007282 |
15 | AMINOGLYCAN BIOSYNTHETIC PROCESS | 4 | 107 | 3.512e-06 | 0.00106 |
16 | MUCOPOLYSACCHARIDE METABOLIC PROCESS | 4 | 108 | 3.645e-06 | 0.00106 |
17 | RESPONSE TO AMINO ACID | 4 | 112 | 4.213e-06 | 0.001107 |
18 | LIPOSACCHARIDE METABOLIC PROCESS | 4 | 114 | 4.521e-06 | 0.001107 |
19 | MEMBRANE LIPID BIOSYNTHETIC PROCESS | 4 | 114 | 4.521e-06 | 0.001107 |
20 | PEPTIDYL ASPARAGINE MODIFICATION | 3 | 39 | 7.638e-06 | 0.001777 |
21 | CERAMIDE BIOSYNTHETIC PROCESS | 3 | 43 | 1.029e-05 | 0.002279 |
22 | RESPONSE TO ACID CHEMICAL | 5 | 319 | 1.274e-05 | 0.002695 |
23 | AMINOGLYCAN METABOLIC PROCESS | 4 | 166 | 1.999e-05 | 0.004044 |
24 | LEUKOCYTE HOMEOSTASIS | 3 | 60 | 2.822e-05 | 0.005471 |
25 | MEMBRANE LIPID METABOLIC PROCESS | 4 | 184 | 2.994e-05 | 0.005572 |
26 | OLIGOSACCHARIDE METABOLIC PROCESS | 3 | 65 | 3.59e-05 | 0.006425 |
27 | SULFUR COMPOUND BIOSYNTHETIC PROCESS | 4 | 203 | 4.395e-05 | 0.007304 |
28 | GLYCOSPHINGOLIPID METABOLIC PROCESS | 3 | 69 | 4.296e-05 | 0.007304 |
29 | CERAMIDE METABOLIC PROCESS | 3 | 73 | 5.086e-05 | 0.008161 |
30 | PROTEIN N LINKED GLYCOSYLATION | 3 | 75 | 5.515e-05 | 0.008554 |
31 | SPHINGOLIPID BIOSYNTHETIC PROCESS | 3 | 77 | 5.967e-05 | 0.008956 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | TRANSFERASE ACTIVITY TRANSFERRING GLYCOSYL GROUPS | 9 | 282 | 2.844e-12 | 2.642e-09 |
2 | TRANSFERASE ACTIVITY TRANSFERRING HEXOSYL GROUPS | 6 | 203 | 3.496e-08 | 1.083e-05 |
3 | GALACTOSYLTRANSFERASE ACTIVITY | 4 | 33 | 2.92e-08 | 1.083e-05 |
4 | UDP GLYCOSYLTRANSFERASE ACTIVITY | 5 | 139 | 2.151e-07 | 4.995e-05 |
5 | SIALYLTRANSFERASE ACTIVITY | 3 | 21 | 1.124e-06 | 0.0002089 |
6 | UDP GALACTOSYLTRANSFERASE ACTIVITY | 3 | 28 | 2.757e-06 | 0.0004269 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | GOLGI APPARATUS | 13 | 1445 | 6.659e-11 | 3.889e-08 |
2 | GOLGI APPARATUS PART | 11 | 893 | 1.536e-10 | 4.485e-08 |
3 | GOLGI MEMBRANE | 10 | 703 | 3.631e-10 | 7.068e-08 |
4 | GOLGI CISTERNA MEMBRANE | 4 | 74 | 7.998e-07 | 0.0001168 |
5 | GOLGI CISTERNA | 4 | 93 | 2.005e-06 | 0.0002342 |
6 | GOLGI STACK | 4 | 125 | 6.52e-06 | 0.0006346 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | FoxO_signaling_pathway_hsa04068 | 3 | 132 | 0.0002951 | 0.009315 | |
2 | PI3K_Akt_signaling_pathway_hsa04151 | 4 | 352 | 0.0003656 | 0.009315 | |
3 | Jak_STAT_signaling_pathway_hsa04630 | 3 | 162 | 0.0005374 | 0.009315 | |
4 | Focal_adhesion_hsa04510 | 3 | 199 | 0.0009763 | 0.01269 | |
5 | Ras_signaling_pathway_hsa04014 | 3 | 232 | 0.001518 | 0.01579 | |
6 | Adherens_junction_hsa04520 | 2 | 72 | 0.002329 | 0.01738 | |
7 | Cytokine_cytokine_receptor_interaction_hsa04060 | 3 | 270 | 0.00234 | 0.01738 | |
8 | MAPK_signaling_pathway_hsa04010 | 3 | 295 | 0.003007 | 0.01796 | |
9 | ErbB_signaling_pathway_hsa04012 | 2 | 85 | 0.003227 | 0.01796 | |
10 | Gap_junction_hsa04540 | 2 | 88 | 0.003454 | 0.01796 | |
11 | HIF_1_signaling_pathway_hsa04066 | 2 | 100 | 0.004435 | 0.02096 | |
12 | Phospholipase_D_signaling_pathway_hsa04072 | 2 | 146 | 0.009226 | 0.03998 | |
13 | Rap1_signaling_pathway_hsa04015 | 2 | 206 | 0.01776 | 0.06716 | |
14 | Regulation_of_actin_cytoskeleton_hsa04810 | 2 | 208 | 0.01808 | 0.06716 |